AstraZeneca moves away from outsourcing, at least in IT

AstraZeneca ($AZN) is looking to bring more of its IT work in-house, spending money to stand up an Indian hub that will replace much of its contract spend in the field. The plan is to expand its operations in Chennai, India, from 75 people to about 300, FierceBiotechIT reports, part of a three-step expansion that will see the drugmaker unveil new IT outposts in San Francisco and Eastern Europe over the next few years. Once the process is complete, AstraZeneca's outsourced IT work will shrink from 70% to 30%, the company said. News

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.